Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ $167.33)
- $167.33 P/E (TTM): 18.61X Cap: $402.98B
- View JNJ Profile
- View Questions on JNJ

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Gilead Sciences Inc. (GILD $113.18)
- $113.18 P/E (TTM): 23.78X Cap: $140.78B
- View GILD Profile
- View Questions on GILD
Intuitive Surgical Inc. (ISRG $483.12)
- $483.12 P/E (TTM): 70.73X Cap: $173.18B
- View ISRG Profile
- View Questions on ISRG
AbbVie Inc. (ABBV $195.22)
- $195.22 P/E (TTM): 83.43X Cap: $344.83B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $167.33)
- $167.33 P/E (TTM): 18.61X Cap: $402.98B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $762.33)
- $762.33 P/E (TTM): 62.03X Cap: $722.48B
- View LLY Profile
- View Questions on LLY
Medtronic plc. (MDT $89.34)
- $89.34 P/E (TTM): 24.75X Cap: $114.46B
- View MDT Profile
- View Questions on MDT
Stryker Corporation (SYK $377.79)
- $377.79 P/E (TTM): 51.05X Cap: $144.37B
- View SYK Profile
- View Questions on SYK
Thermo Fisher Scientific Inc (TMO $463.04)
- $463.04 P/E (TTM): 27.16X Cap: $174.79B
- View TMO Profile
- View Questions on TMO
Health Care Select Sector SPDR (XLV $131.13)
- $131.13 P/E (TTM): 65.74X Cap: $32.75B
- View XLV Profile
- View Questions on XLV
iShares U.S. Medical Devices ETF (IHI $59.66)
- $59.66 P/E (TTM): 105.73X Cap: $4.25B
- View IHI Profile
- View Questions on IHI
Sabra Health Care REIT Inc. (SBRA $18.29)
- $18.29 P/E (TTM): 30.79X Cap: $4.35B
- View SBRA Profile
- View Questions on SBRA
Healthcare Realty Trust Incorporated (HR $16.54)
- $16.54 Cap: $5.81B
- View HR Profile
- View Questions on HR
iShares U.S. Pharmaceuticals ETF (IHE $66.79)
- $66.79 P/E (TTM): 57.72X Cap: $547M
- View IHE Profile
- View Questions on IHE
Catalyst Pharmaceuticals Inc. (CPRX $21.12)
- $21.12 P/E (TTM): 13.45X Cap: $2.57B
- View CPRX Profile
- View Questions on CPRX

Q: There was an article in the Globe and Mail today by David Rosenberg about the aging population and he suggested health care related investments such as health care REITS, pharma, devices, and services. What do you think of this idea and can you give me a few recommendations in canada and the US for each of the 4 categories (health reits, pharma, devices, sefrvices)? A mix of ETFS and individual stocks would be great.

Read Answer Asked by Carla on July 08, 2025

Microsoft Corporation (MSFT $524.11)
- $524.11 P/E (TTM): 40.53X Cap: $3.89T
- View MSFT Profile
- View Questions on MSFT
Johnson & Johnson (JNJ $167.33)
- $167.33 P/E (TTM): 18.61X Cap: $402.98B
- View JNJ Profile
- View Questions on JNJ
Procter & Gamble Company (The) (PG $150.65)
- $150.65 P/E (TTM): 23.91X Cap: $353.20B
- View PG Profile
- View Questions on PG
Philip Morris International Inc (PM $162.96)
- $162.96 P/E (TTM): 30.92X Cap: $253.66B
- View PM Profile
- View Questions on PM

Q: If you were looking specifically at dividend safety and dividend growth, what would you prefer to own, JNJ or PG and why? is there another dividend growth company you would prefer for a US dividend account?

Read Answer Asked by Frank on June 30, 2025

Johnson & Johnson (JNJ $167.33)
- $167.33 P/E (TTM): 18.61X Cap: $402.98B
- View JNJ Profile
- View Questions on JNJ
Toronto-Dominion Bank (The) (TD $100.09)
- $100.09 P/E (TTM): 10.24X Cap: $172.40B
- View TD Profile
- View Questions on TD

Q: Both TD and J&J have become to large in my RRIF and I need to rebalance and sell some shares. What stocks would you suggest would be good alternatives to both. I do own RBC.

Thanks

Wayne

Read Answer Asked by Wayne on June 09, 2025